APstem Therapeutics, Inc.

company

About

NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$2.80M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

With APstem Therapeutics’ breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™), we are on a mission to eradicate difficult-to-heal diseases and conquer the challenges of aging.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$4.30M
APstem Therapeutics, Inc. has raised a total of $4.30M in funding over 2 rounds. Their latest funding was raised on Sep 1, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 1, 2020 Seed $2.80M 1 Detail
May 1, 2019 Seed $500K 1 Detail
Aug 1, 2018 Seed $1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
APstem Therapeutics, Inc. is funded by 1 investors. Magic Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Magic Capital Seed